tailieunhanh - ANTIVIRAL AGENTS VACCINES AND IMMUNOTHERAPIES

The development of antiviral drugs is still in its infancy with rapid changes and progressive milestones encountered almost daily. By the time this book is distributed, new drugs may have already been added. This is particularly true for the antiretroviral drugs, which seem to be growing in number exponentially to the casual observer trying to keep abreast of recent advances in this field. As | Antiviral Agents Vaccines and Immunotherapies stephen K. Tyring Library of Congress Cataloging-in-Publication Data Catalog record is available from the Library of Congress This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use. Neither this book nor any part may be reproduced or transmitted in any form or by any means electronic or mechanical including photocopying microfilming and recording or by any information storage or retrieval system without prior permission in writing from the publisher. The consent of Marcel Dekker and CRC Press does not extend to copying for general distribution for promotion for creating new works or for resale. Specific permission must be obtained in writing from Marcel Dekker CRC Press for such copying. Direct all inquiries to CRC Press 2000 . Corporate Blvd. Boca Raton Florida 33431. Trademark Notice Product or corporate names may be trademarks or registered trademarks and are used only for identification and explanation without intent to infringe. Visit the CRC Press Web site at 2005 by Marcel Dekker CRC Press No claim to original . Government works International Standard Book Number 0-8247-5408-5 Printed in the United States of America 1 2 3 4 5 6 78 9 0 Printed on acid-free paper Preface The development of antiviral drugs is still in its infancy with rapid changes and progressive milestones encountered almost daily. By the time this book is distributed new drugs may have already been added. This is particularly true for the antiretroviral drugs which seem to be growing in number exponentially to the casual observer trying to keep abreast of recent advances in this .